Annual Operating Margin
-23.67%
-1.50%-6.77%
31 December 2023
Summary:
Akebia Therapeutics annual operating profit margin is currently -23.67%, with the most recent change of -1.50% (-6.77%) on 31 December 2023. During the last 3 years, it has risen by +104.56% (+81.54%). AKBA annual operating margin is now -6.77% below its all-time high of -22.17%, reached on 31 December 2022.AKBA Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-33.41%
-13.42%-67.13%
30 September 2024
Summary:
Akebia Therapeutics quarterly operating profit margin is currently -33.41%, with the most recent change of -13.42% (-67.13%) on 30 September 2024. Over the past year, it has dropped by -2.81% (-9.18%). AKBA quarterly operating margin is now -186.87% below its all-time high of 38.46%, reached on 30 June 2022.AKBA Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.8% | -9.2% |
3 y3 years | +81.5% | +70.3% |
5 y5 years | +72.4% | +45.0% |
AKBA Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -6.8% | +81.5% | -186.9% | +70.5% |
5 y | 5 years | -6.8% | +81.5% | -186.9% | +82.7% |
alltime | all time | -6.8% | +99.7% | -186.9% | +98.7% |
Akebia Therapeutics Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -33.41%(+67.1%) |
June 2024 | - | -19.99%(-56.2%) |
Mar 2024 | - | -45.63%(-1962.4%) |
Dec 2023 | -23.67%(+6.8%) | 2.45%(-108.0%) |
Sept 2023 | - | -30.60%(+89.8%) |
June 2023 | - | -16.12%(-74.7%) |
Mar 2023 | - | -63.72%(+874.3%) |
Dec 2022 | -22.17%(-82.3%) | -6.54%(-93.7%) |
Sept 2022 | - | -103.10%(-368.1%) |
June 2022 | - | 38.46%(-140.6%) |
Mar 2022 | - | -94.80%(-16.3%) |
Dec 2021 | -124.97%(-2.5%) | -113.28%(+0.6%) |
Sept 2021 | - | -112.57%(-24.9%) |
June 2021 | - | -149.95%(+20.8%) |
Mar 2021 | - | -124.15%(-19.8%) |
Dec 2020 | -128.23% | -154.88%(+59.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | -96.84%(-49.8%) |
June 2020 | - | -192.83%(+188.6%) |
Mar 2020 | - | -66.82%(-51.0%) |
Dec 2019 | -85.46%(-0.3%) | -136.43%(+124.5%) |
Sept 2019 | - | -60.78%(+2.9%) |
June 2019 | - | -59.05%(-43.5%) |
Mar 2019 | - | -104.55%(-30.6%) |
Dec 2018 | -85.76%(+102.7%) | -150.64%(+187.6%) |
Sept 2018 | - | -52.37%(-28.3%) |
June 2018 | - | -73.09%(+37.0%) |
Mar 2018 | - | -53.34%(-430.7%) |
Dec 2017 | -42.31%(-99.5%) | 16.13%(-127.5%) |
Sept 2017 | - | -58.56%(-24.6%) |
June 2017 | - | -77.62%(-64.0%) |
Mar 2017 | - | -215.54%(-91.3%) |
Dec 2016 | -8889.90% | -2478.44% |
FAQ
- What is Akebia Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Akebia Therapeutics?
- What is Akebia Therapeutics annual operating margin year-on-year change?
- What is Akebia Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly operating margin year-on-year change?
What is Akebia Therapeutics annual operating profit margin?
The current annual operating margin of AKBA is -23.67%
What is the all time high annual operating margin for Akebia Therapeutics?
Akebia Therapeutics all-time high annual operating profit margin is -22.17%
What is Akebia Therapeutics annual operating margin year-on-year change?
Over the past year, AKBA annual operating profit margin has changed by -1.50% (-6.77%)
What is Akebia Therapeutics quarterly operating profit margin?
The current quarterly operating margin of AKBA is -33.41%
What is the all time high quarterly operating margin for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly operating profit margin is 38.46%
What is Akebia Therapeutics quarterly operating margin year-on-year change?
Over the past year, AKBA quarterly operating profit margin has changed by -2.81% (-9.18%)